Latest:
Navigating Data Integrity for Generic Drug Approvals
© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to Classification
Latest:
Opinion: Purple Book Patent Listings Are Only a First Step
Latest:
Dr Prerakkumar Parikh Reacts to FDA Approvals for First Neurology, Tocilizumab Biosimilars
Latest:
Contributor: Self-Administered Biosimilars Are Coming Quickly—Is Your Clinic Ready?
Latest:
Julie Reed On How the Biosimilars Forum is Helping FDA Catch Up on Biosimilar Inspections